Ullmann Wealth Partners Group’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-416	Closed	-$10K	–	105
2017 Q2	$10K	Hold	416	–	–	0.01%	140
2017 Q1	$7K	Buy	+416	New	+$7K	0.01%	135